Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
115 studies found for:    Open Studies | "Nephritis"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting ACTHar in the Treatment of Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: CellCept;   Drug: ACTHar gel
2 Unknown  Effect of Mesenchymal Stem Cell Transplantation for Lupus Nephritis
Condition: Lupus Nephritis
Intervention: Biological: mesenchymal stem cell
3 Recruiting Xolair (Omalizumab) for Treatment of Drug-induced Acute Tubulointerstitial Nephritis (AIN)
Condition: Acute Interstitial Nephritis
Interventions: Drug: Omalizumab;   Drug: Prednisone
4 Unknown  Efficacy and Safety of Tripterygium Wilfordii in Patients With Lupus Nephritis
Condition: Nephritis, Lupus
Interventions: Drug: Tripterygium wilfordii Hook F;   Drug: Cyclophosphamide;   Drug: GC
5 Recruiting RING - Rituximab for Lupus Nephritis With Remission as a Goal
Condition: Lupus Nephritis
Interventions: Drug: RTX infusions;   Other: Standard of Care
6 Recruiting Mycophenolic Acid Pharmacokinetics and Pharmacogenomics in Lupus Nephritis
Condition: Lupus Nephritis
Intervention:
7 Recruiting Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Placebo plus standard therapy;   Biological: Belimumab 10 mg/kg plus standard therapy;   Drug: Standard therapy
8 Recruiting Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) for Induction of Remission in Lupus Nephritis
Condition: Lupus Nephritis
Intervention: Drug: Tacrolimus vs. Mycophenolate mofetil for Induction Therapy in Lupus Nephritis
9 Recruiting Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Tacrolimus;   Drug: Mycophenolate mofetil
10 Recruiting A Study to Compare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Tacrolimus capsules;   Drug: Cyclophosphamide injections;   Drug: Prednisone
11 Unknown  Phase 2 Study of Human Umbilical Cord Derived Mesenchymal Stem Cell for the Treatment of Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Human Umbilical Cord derived MSCs;   Drug: Cyclophosphamide
12 Recruiting Safety and Efficacy of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Proliferative Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Anifrolumab;   Drug: Placebo
13 Recruiting Trial of Rituximab and Mycophenolate Mofetil Without Oral Steroids for Lupus Nephritis
Condition: Systemic Lupus Erythematosus, Lupus Nephritis
Interventions: Drug: Oral prednisolone;   Drug: Rituximab;   Drug: Mycophenolate mofetil;   Drug: Methyl prednisolone
14 Not yet recruiting Cohort Study on Traditional Chinese Medicine Diagnosis and Treatment of Children With Henoch-Schonlein Purpura Nephritis
Condition: Henoch-Schonlein Purpura Nephritis
Interventions: Drug: Qi ji shen kang lotion;Zhubai lotion;More Kidney lotion;   Drug: Angiotensin-converting enzyme inhibitor orangiotensin II receptor blocker ;Tripterygium Glycosides;Adrenocorticotropic hormone ;Other Immunosuppressant
15 Recruiting Rituximab and Belimumab for Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Rituximab;   Drug: Cyclophosphamide;   Drug: Prednisone;   Drug: Methylprednisolone;   Drug: Diphenhydramine;   Drug: Acetaminophen;   Biological: Belimumab
16 Recruiting Comparison of Low Dose Versus High Dose Cyclophosphamide as Induction Therapy in the Treatment of Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Cyclophosphamide;   Drug: Azathioprine;   Drug: Methylprednisolone
17 Recruiting A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Mizoribine (MZR);   Drug: Cyclophosphamide (CTX)
18 Recruiting Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: BI 655064 dose 1;   Drug: BI 655064 dose 2;   Drug: BI 655064 dose 3;   Drug: Placebo
19 Recruiting Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Ixazomib in Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Ixazomib;   Drug: Placebo
20 Recruiting A Study to Evaluate the Safety and Efficacy of Obinutuzumab, an Antibody Targeting Certain Types of Immune Cells, in Participants With Lupus Nephritis (LN)
Condition: Lupus Nephritis
Interventions: Drug: Mycophenolate Mofetil;   Drug: Obinutuzumab;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years